Integrated workflows ease staff burden and satisfy regulatory mandates.

Two decades ago, the pharmacy industry had a chance to cement its role as a collaborative clinical partner, but a seemingly logical decision unintentionally sidelined pharmacists from the care process. In a new article, DrFirst CEO G. Cameron Deemer explains how applying claims-based thinking to e-prescribing shut pharmacists out of meaningful clinical engagement—and what it will take to fix that now.
The implications are enormous for everyone involved, including pharmacists, prescribers, payers, and (most of all) patients. Prescription workflows don’t just move data—they shape care decisions, speed to therapy, and patient outcomes. It’s time to rethink the behind-the-scenes infrastructure and ask: What would it look like if we built e-prescribing around clinical collaboration instead of claims processing?
Read the article in Chain Drug Review to explore what’s next for pharmacy innovation and how we can finally get it right.
